166 related articles for article (PubMed ID: 2156001)
1. Passive immunization protects the mouse eye from damage after herpes simplex virus infection by limiting spread of virus in the nervous system.
Shimeld C; Hill TJ; Blyth WA; Easty DL
J Gen Virol; 1990 Mar; 71 ( Pt 3)():681-7. PubMed ID: 2156001
[TBL] [Abstract][Full Text] [Related]
2. An improved model of recurrent herpetic eye disease in mice.
Shimeld C; Hill T; Blyth B; Easty D
Curr Eye Res; 1989 Nov; 8(11):1193-205. PubMed ID: 2558849
[TBL] [Abstract][Full Text] [Related]
3. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.
Morrison LA; Knipe DM
Virology; 1997 Dec; 239(2):315-26. PubMed ID: 9434723
[TBL] [Abstract][Full Text] [Related]
4. Spread of virus and distribution of latent infection following ocular herpes simplex in the non-immune and immune mouse.
Tullo AB; Shimeld C; Blyth WA; Hill TJ; Easty DL
J Gen Virol; 1982 Nov; 63 (Pt 1)():95-101. PubMed ID: 6294236
[TBL] [Abstract][Full Text] [Related]
5. Previous immunization of mice with herpes simplex virus type-1 strain MP protects against secondary corneal infection.
Sandstrom IK; Foster CS; Wells PA; Knipe D; Caron L; Greene MI
Clin Immunol Immunopathol; 1986 Aug; 40(2):326-34. PubMed ID: 3013476
[TBL] [Abstract][Full Text] [Related]
6. Non-traumatic acquisition of herpes simplex virus infection through the eye.
Kaye SB; Shimeld C; Grinfeld E; Maitland NJ; Hill TJ; Easty DL
Br J Ophthalmol; 1992 Jul; 76(7):412-8. PubMed ID: 1320925
[TBL] [Abstract][Full Text] [Related]
7. Endogenously produced interferon alpha protects mice from herpes simplex virus type 1 corneal disease.
Hendricks RL; Weber PC; Taylor JL; Koumbis A; Tumpey TM; Glorioso JC
J Gen Virol; 1991 Jul; 72 ( Pt 7)():1601-10. PubMed ID: 1649898
[TBL] [Abstract][Full Text] [Related]
8. Reactivation of latent infection and induction of recurrent herpetic eye disease in mice.
Shimeld C; Hill TJ; Blyth WA; Easty DL
J Gen Virol; 1990 Feb; 71 ( Pt 2)():397-404. PubMed ID: 2155293
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulation of experimental murine herpes simplex keratitis: II. Glycoprotein D protection.
Foster CS; Sandstrom IK; Wells PA; Thompson P; Daigle J; Opremcak EM
Curr Eye Res; 1988 Nov; 7(11):1051-61. PubMed ID: 2854037
[TBL] [Abstract][Full Text] [Related]
10. Spread of herpes simplex virus within ocular nerves of the mouse: demonstration of viral antigen in whole mounts of eye tissue.
Dyson H; Shimeld C; Hill TJ; Blyth WA; Easty DL
J Gen Virol; 1987 Dec; 68 ( Pt 12)():2989-95. PubMed ID: 2826644
[TBL] [Abstract][Full Text] [Related]
11. Immunobiology of Langerhans cells on the ocular surface. II. Role of central corneal Langerhans cells in stromal keratitis following experimental HSV-1 infection in mice.
McLeish W; Rubsamen P; Atherton SS; Streilein JW
Reg Immunol; 1989; 2(4):236-43. PubMed ID: 2561960
[TBL] [Abstract][Full Text] [Related]
12. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.
Ritchie MH; Oakes JE; Lausch RN
Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2460-8. PubMed ID: 8392037
[TBL] [Abstract][Full Text] [Related]
13. Lyt-1+ T cells participate in recovery from ocular herpes simplex virus type 1 infection.
Oakes JE; Rector JT; Lausch RN
Invest Ophthalmol Vis Sci; 1984 Feb; 25(2):188-94. PubMed ID: 6321384
[TBL] [Abstract][Full Text] [Related]
14. Spread of HSV and establishment of latency after corneal infection in inbred mice.
Abghari SZ; Stulting RD; Nigida SM; Downer DN; Nahmias AJ
Invest Ophthalmol Vis Sci; 1986 Jan; 27(1):77-82. PubMed ID: 3000975
[TBL] [Abstract][Full Text] [Related]
15. Ocular herpes simplex virus reactivation in mice latently infected with latency-associated transcript mutants.
Cook SD; Paveloff MJ; Doucet JJ; Cottingham AJ; Sedarati F; Hill JM
Invest Ophthalmol Vis Sci; 1991 Apr; 32(5):1558-61. PubMed ID: 1849874
[TBL] [Abstract][Full Text] [Related]
16. Recovery of herpes simplex virus from the corneas of experimentally infected rabbits.
Cook SD; Batra SK; Brown SM
J Gen Virol; 1987 Jul; 68 ( Pt 7)():2013-7. PubMed ID: 3037020
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulation of experimental murine herpes simplex keratitis: I. UV-HSV protection.
Thompson P; Wells PA; Sandstrom IK; Opremcak EM; Millin JA; Daigle JA; Foster CS
Curr Eye Res; 1988 Nov; 7(11):1043-9. PubMed ID: 2854036
[TBL] [Abstract][Full Text] [Related]
18. Effect of immunization and immunosuppression on induced ocular shedding and recovery of herpes simplex virus in infected rabbits.
Green MT; Dunkel EC; Pavan-Langston D
Exp Eye Res; 1987 Sep; 45(3):375-83. PubMed ID: 2822456
[TBL] [Abstract][Full Text] [Related]
19. Innate and acquired immunity to herpes simplex virus type 1.
Halford WP; Veress LA; Gebhardt BM; Carr DJ
Virology; 1997 Sep; 236(2):328-37. PubMed ID: 9325240
[TBL] [Abstract][Full Text] [Related]
20. Ocular herpes simplex and the establishment of latent infection.
Tullo AB; Easty DL; Hill TJ; Blyth WA
Trans Ophthalmol Soc U K (1962); 1982 Apr; 102 (Pt 1)():15-8. PubMed ID: 6301114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
